Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_assertion type Assertion NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_head.
- NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_assertion description "[We found that YM155 induced apoptosis by broad-spectrum inhibition of IAP family member proteins (e.g., CIAP1/2 and FLIP) and induced proapoptotic Bak protein upregulation and activation; the antitumor effect of YM155 treatment with either the DR5 agonist lexatumumab or gemcitabine on pancreatic cancer cells was synergistic.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_provenance.
- NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_assertion evidence source_evidence_literature NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_provenance.
- NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_assertion SIO_000772 25344582 NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_provenance.
- NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_assertion wasDerivedFrom befree-2016 NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_provenance.
- NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_assertion wasGeneratedBy ECO_0000203 NP1232492.RAhRG2n1T6-fIKJOAyoNnCYgaGnV6xw3DcF15vA9ti8dY130_provenance.